BLOG
Executive Summary Over the past 45 days, Ohio’s cannabis market has moved from initial rollout into a more structured, compliance-driven phase. Senate Bill 56, effective March 20, 2026, introduces regulatory guardrails across both medical and adult-use frameworks, while also addressing intoxicating hemp products, public consumption, and tax allocation. At the same time, federal momentum toward … Continue reading “Ohio Cannabis Policy Update: SB 56 Reshapes Adult-Use and Hemp Regulations”
Executive Summary On April 23, 2026, the U.S. Department of Justice issued a final order placing FDA-approved marijuana products and marijuana products used within state-licensed medical frameworks into Schedule III of the Controlled Substances Act. This marks the first time in over 50 years that any category of marijuana has been formally reclassified at the … Continue reading “Federal Rescheduling Update: A Targeted Shift and What It Means for the Cannabis Industry”
Executive Summary Over the past 45 days, Idaho’s cannabis landscape has shifted. Supporters of the Idaho Medical Cannabis Act have continued signature gathering ahead of the April 30 submission deadline, reporting more than 73,000 signatures in March and more than 100,000 by mid-April. At the same time, state lawmakers have advanced both political and constitutional … Continue reading “Idaho Cannabis Policy Update: Ballot Momentum Builds”
IT’S TIME TO GET GROWING.
Better growth and a clear plan forward is what your business needs. Reach out to us to book a consultation or get your action plan
started.